Vitro Diagnostics Market Synopsis

Vitro Diagnostics Market Size is Valued at USD 74.92 Billion in 2023 and is Projected to Reach USD 117.60 Billion by 2032, Growing at a CAGR of 6.0% From 2024-2032.

The Vitro Diagnostics Market covers tests and equipment that involve analyzing samples, which are derived from the human body, in a system other than the patient’s body. The products and techniques that fall under this market are immunoassays and clinical chemistry products as well as next-generation molecular diagnostic tests. Main areas are cancer; cardiovascular diseases; infectious diseases; diabetes and others. It targets hospitals, diagnostic laboratories, and research facilities as end-users, and constant product development and technologies’ enhancement is a big aspect of the market as the main goal is to achieve more precise diagnostics and better patient outcomes.

• MDW is the major driver for the vitro diagnostics market since chronic and infectious diseases are on the rise globally. Thus there are increasing needs for efficient diagnostic tools as the global population age increases and there are more indications like cancer, cardiovascular diseases, diabetes. Technological developments in others diseases diagnostic techniques such as molecular diagnostics or new immunoassays are helping the early diagnosis, thus supporting increased market growth. In addition, the global trend towards being proactive about one’s health, as well as the transition to individualized medicine, requires healthcare facilities and patients to turn to highly effective diagnostic tools.
• The other strong influencer is advancement in technology and new innovations in the in vitro diagnostic (IVD) products. Currently the immune screening, high production NGS and the advanced diagnostic platforms are enhancing the disease detection rate. Also, the growth of the health care facilities and the increasing expenditure on the health care sectors due to more awareness in the emerging markets are other reasons for the growth of the vitro diagnostics market. More government programs and grants for research and development in the diagnostics contribute to the development of this market by providing incentives to make new diagnoses products.

Vitro Diagnostics Market Trend Analysis

Increasing Applications in the Automotive Industry

• The vitro diagnostics market is in a growing situation due to the factors such as technological developments and rise in the need for diagnosing diseases at an earlier stage with better precision. Some trends that have been identified are; molecular diagnostics is becoming widespread, and next-generation sequencing that are faster and more accurate than the conventional methods. Moreover, the use of artificial intelligence and machine learning in diagnostics, the development of new diagnostic tools indicated the increase of accuracy in test results contributing to patients’ treatment. The rise in the incidence rate of chronic diseases like cancer and diabetes also adds to the requirement for superior diagnostic modalities especially in the developed countries.
• As per demand of specific therapeutic strategies, diagnostic tests are also shifting towards more targeted approach on the grounds that individualization is changing the industry. This is in line with the growth of biomarker-based diagnosis and the Company’s focus on the provision of companion diagnostics. Also, increase in the role of preventive healthcare and home diagnostics solutions is changing the face of diagnostics, making it easier and convenient. The Asia-Pacific and Latin American markets are anticipated to grow due to enhanced health care structures as the region spends more on this sector.

Emerging Opportunities in the In Vitro Diagnostics Market, Advancements and Growth Drivers

• Certainly, favourable macro factors exist for the IVD market since the occurrence rates of cardiovascular diseases, cancer, and infections continue to rise globally, thereby propelling growth in the sector. Future developments like enhancement of the diagnosed test or other diagnostic equipment and the popularization of individual treatment approaches will help to stimulate the market forecasts. Also, the increasing cost of healthcare and investment in infrastructure mainly in the emerging nations are some factors that help the market grow. Artificial intelligence and digital health technologies are also incorporated into the diagnostic processes and present some prospects for IVD industry development.
•  Going hand in hand with this indicator, the second significant opportunity can be noted, which is the increasing popularity of preventive measures and early diagnostics. During the current era of the increased focus on health and prevention, people need highly developed diagnostic tools to improve the detection of diseases and start the treatment at an early stage. Additionally, home-based testing solutions and point of care diagnostics segment has been continuously growing which is somehow making it easier for the patients to get their diagnostic tests done hence contributing in the high growth of the market. Research and development and strategic alliances and acquisitions definitely will improve the market stakeholders in IVD industry.

Vitro Diagnostics Market Segment Analysis:

Vitro Diagnostics Market Segmented on the basis of Product, Technique, application, and end-users.

By Product, Instruments segment is expected to dominate the market during the forecast period

• The in vitro diagnostics (IVD) market is segmented by product into several key categories: of; instruments, reagents, software, and others. Gadgets include the different equipments that are used in procedures related to diagnosis while chemistries include the chemicals that are required in the performance of tests. Software entails the digital tools that help in support of diagnostic processes and data management. The ‘others’ subsector comprises of any other products that may be offered albeit not belonging to the core segments in IVD market.

By Technique, the Immunoassays segment held the largest share in 2024

• The in vitro diagnostics (IVD) market is segmented by technique into several core areas: are immunological assays, clinical chemistry, molecular biology, hematology, microbiology, and others. Immunoassays are basically screening techniques that can help in the identification and measurement of certain proteins and antibodies while clinical chemistry mainly deals with the testing of body fluids which indeed can help in the diagnosis of certain diseases. Molecular diagnostics encompasses identification of Dna or rna sequences, hematology is the science of blood and its diseases while microbiology is the identification of microorganisms. The ‘other’ segment is there to incorporate any additional diagnostic procedure that has not been classified under the above said primary segment but is related to the market.

Vitro Diagnostics Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America holds the largest IVD market as the region possesses well-developed healthcare structures and actively implements-new diagnostic technologies. The region has access to a large market of IVD equipment, a high level of development of the industry this year, large investments in research and development in this topic, and information on the importance of early diagnosis of diseases and personalized medicine. For instance, the United States contributes a large share of this market relatively to its population size, expenditure on healthcare and favorable regulations on development of technology. Moreover, more people are developing chronic diseases, and the global population is living longer, which both create more need for diagnostics.
• Thus, it is envisioned that in Canada the IVD market will continue to expand, receiving impetus from the established governmental health care programs and initiation of population Health-conscious approach mechanism. The region enjoys strong and developed health care sectors and good triangle between research centers and industry participants. Other significant characteristics of the North America’s market include the focus on the compliance with the regulations as well as the inclusion of the digital health technologies. The constant innovation of new diagnostic techniques such as the molecular diagnostics in conjunction with point of care diagnostics is also likely to fuel the market growth because of a push for not only early, but also accurate diagnosis of diseases in healthcare services.

Active Key Players in the Vitro Diagnostics Market

• Roche Diagnostics (Switzerland)
• Abbott Laboratories (United States)
• Siemens Healthineers (Germany)
• Thermo Fisher Scientific (United States)
• Danaher Corporation (United States)
• BD (Becton, Dickinson and Company) (United States)
• Johnson & Johnson (United States)
• Bio-Rad Laboratories (United States)
• Ortho Clinical Diagnostics (United States)
• Quidel Corporation (United States)
• Hologic, Inc. (United States)
• Sysmex Corporation (Japan)
• PerkinElmer, Inc. (United States)
• Agilent Technologies (United States)
• Cepheid (a Danaher company) (United States)
• Others

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Vitro Diagnostics Market by Product
 4.1 Vitro Diagnostics Market Snapshot and Growth Engine
 4.2 Vitro Diagnostics Market Overview
 4.3 Instruments
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Instruments: Geographic Segmentation Analysis
 4.4 Reagents
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Reagents: Geographic Segmentation Analysis
 4.5 Software
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Software: Geographic Segmentation Analysis
 4.6 Others
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Others: Geographic Segmentation Analysis

Chapter 5: Vitro Diagnostics Market by Technique
 5.1 Vitro Diagnostics Market Snapshot and Growth Engine
 5.2 Vitro Diagnostics Market Overview
 5.3 Immunoassays
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Immunoassays: Geographic Segmentation Analysis
 5.4 Clinical Chemistry
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Clinical Chemistry: Geographic Segmentation Analysis
 5.5 Molecular Diagnostics
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Molecular Diagnostics: Geographic Segmentation Analysis
 5.6 Hematology
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Hematology: Geographic Segmentation Analysis
 5.7 Microbiology
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Microbiology: Geographic Segmentation Analysis
 5.8 Others
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Others: Geographic Segmentation Analysis

Chapter 6: Vitro Diagnostics Market by Application
 6.1 Vitro Diagnostics Market Snapshot and Growth Engine
 6.2 Vitro Diagnostics Market Overview
 6.3 Cancer Diagnostics
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Cancer Diagnostics: Geographic Segmentation Analysis
 6.4 Cardiovascular Diagnostics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Cardiovascular Diagnostics: Geographic Segmentation Analysis
 6.5 Infectious Disease Diagnostics
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Infectious Disease Diagnostics: Geographic Segmentation Analysis
 6.6 Neurological Diagnostics
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Neurological Diagnostics: Geographic Segmentation Analysis
 6.7 Pregnancy and Fertility Diagnostics
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Pregnancy and Fertility Diagnostics: Geographic Segmentation Analysis
 6.8 Diabetes Diagnostics
  6.8.1 Introduction and Market Overview
  6.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.8.3 Key Market Trends, Growth Factors and Opportunities
  6.8.4 Diabetes Diagnostics: Geographic Segmentation Analysis
 6.9 Others
  6.9.1 Introduction and Market Overview
  6.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.9.3 Key Market Trends, Growth Factors and Opportunities
  6.9.4 Others: Geographic Segmentation Analysis

Chapter 7: Vitro Diagnostics Market by End-User
 7.1 Vitro Diagnostics Market Snapshot and Growth Engine
 7.2 Vitro Diagnostics Market Overview
 7.3 Hospitals
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals: Geographic Segmentation Analysis
 7.4 Diagnostic Laboratories
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Diagnostic Laboratories: Geographic Segmentation Analysis
 7.5 Research Institutions
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Research Institutions: Geographic Segmentation Analysis
 7.6 Home Care
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Home Care: Geographic Segmentation Analysis
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Vitro Diagnostics Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions
  
 8.2 ROCHE DIAGNOSTICS (SWITZERLAND)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 ABBOTT LABORATORIES (UNITED STATES)
 8.4 SIEMENS HEALTHINEERS (GERMANY)
 8.5 THERMO FISHER SCIENTIFIC (UNITED STATES)
 8.6 DANAHER CORPORATION (UNITED STATES)
 8.7 BD (BECTON
 8.8 DICKINSON AND COMPANY) (UNITED STATES)
 8.9 JOHNSON & JOHNSON (UNITED STATES)
 8.10 BIO-RAD LABORATORIES (UNITED STATES)
 8.11 ORTHO CLINICAL DIAGNOSTICS (UNITED STATES)
 8.12 QUIDEL CORPORATION (UNITED STATES)
 8.13 HOLOGIC INC (UNITED STATES)
 8.14 SYSMEX CORPORATION (JAPAN)
 8.15 PERKINELMER INC (UNITED STATES)
 8.16 AGILENT TECHNOLOGIES (UNITED STATES)
 8.17 CEPHEID (A DANAHER COMPANY) (UNITED STATES)
 8.18 OTHER MAJOR PLAYERS

Chapter 9: Global Vitro Diagnostics Market By Region
 9.1 Overview
 9.2. North America Vitro Diagnostics Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Product
   9.2.4.1 Instruments
   9.2.4.2 Reagents
   9.2.4.3 Software
   9.2.4.4 Others
  9.2.5 Historic and Forecasted Market Size By Technique
   9.2.5.1 Immunoassays
   9.2.5.2 Clinical Chemistry
   9.2.5.3 Molecular Diagnostics
   9.2.5.4 Hematology
   9.2.5.5 Microbiology
   9.2.5.6 Others
  9.2.6 Historic and Forecasted Market Size By Application
   9.2.6.1 Cancer Diagnostics
   9.2.6.2 Cardiovascular Diagnostics
   9.2.6.3 Infectious Disease Diagnostics
   9.2.6.4 Neurological Diagnostics
   9.2.6.5 Pregnancy and Fertility Diagnostics
   9.2.6.6 Diabetes Diagnostics
   9.2.6.7 Others
  9.2.7 Historic and Forecasted Market Size By End-User
   9.2.7.1 Hospitals
   9.2.7.2 Diagnostic Laboratories
   9.2.7.3 Research Institutions
   9.2.7.4 Home Care
   9.2.7.5 Others
  9.2.8 Historic and Forecast Market Size by Country
   9.2.8.1 US
   9.2.8.2 Canada
   9.2.8.3 Mexico
 9.3. Eastern Europe Vitro Diagnostics Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Product
   9.3.4.1 Instruments
   9.3.4.2 Reagents
   9.3.4.3 Software
   9.3.4.4 Others
  9.3.5 Historic and Forecasted Market Size By Technique
   9.3.5.1 Immunoassays
   9.3.5.2 Clinical Chemistry
   9.3.5.3 Molecular Diagnostics
   9.3.5.4 Hematology
   9.3.5.5 Microbiology
   9.3.5.6 Others
  9.3.6 Historic and Forecasted Market Size By Application
   9.3.6.1 Cancer Diagnostics
   9.3.6.2 Cardiovascular Diagnostics
   9.3.6.3 Infectious Disease Diagnostics
   9.3.6.4 Neurological Diagnostics
   9.3.6.5 Pregnancy and Fertility Diagnostics
   9.3.6.6 Diabetes Diagnostics
   9.3.6.7 Others
  9.3.7 Historic and Forecasted Market Size By End-User
   9.3.7.1 Hospitals
   9.3.7.2 Diagnostic Laboratories
   9.3.7.3 Research Institutions
   9.3.7.4 Home Care
   9.3.7.5 Others
  9.3.8 Historic and Forecast Market Size by Country
   9.3.8.1 Bulgaria
   9.3.8.2 The Czech Republic
   9.3.8.3 Hungary
   9.3.8.4 Poland
   9.3.8.5 Romania
   9.3.8.6 Rest of Eastern Europe
 9.4. Western Europe Vitro Diagnostics Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Product
   9.4.4.1 Instruments
   9.4.4.2 Reagents
   9.4.4.3 Software
   9.4.4.4 Others
  9.4.5 Historic and Forecasted Market Size By Technique
   9.4.5.1 Immunoassays
   9.4.5.2 Clinical Chemistry
   9.4.5.3 Molecular Diagnostics
   9.4.5.4 Hematology
   9.4.5.5 Microbiology
   9.4.5.6 Others
  9.4.6 Historic and Forecasted Market Size By Application
   9.4.6.1 Cancer Diagnostics
   9.4.6.2 Cardiovascular Diagnostics
   9.4.6.3 Infectious Disease Diagnostics
   9.4.6.4 Neurological Diagnostics
   9.4.6.5 Pregnancy and Fertility Diagnostics
   9.4.6.6 Diabetes Diagnostics
   9.4.6.7 Others
  9.4.7 Historic and Forecasted Market Size By End-User
   9.4.7.1 Hospitals
   9.4.7.2 Diagnostic Laboratories
   9.4.7.3 Research Institutions
   9.4.7.4 Home Care
   9.4.7.5 Others
  9.4.8 Historic and Forecast Market Size by Country
   9.4.8.1 Germany
   9.4.8.2 UK
   9.4.8.3 France
   9.4.8.4 Netherlands
   9.4.8.5 Italy
   9.4.8.6 Russia
   9.4.8.7 Spain
   9.4.8.8 Rest of Western Europe
 9.5. Asia Pacific Vitro Diagnostics Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Product
   9.5.4.1 Instruments
   9.5.4.2 Reagents
   9.5.4.3 Software
   9.5.4.4 Others
  9.5.5 Historic and Forecasted Market Size By Technique
   9.5.5.1 Immunoassays
   9.5.5.2 Clinical Chemistry
   9.5.5.3 Molecular Diagnostics
   9.5.5.4 Hematology
   9.5.5.5 Microbiology
   9.5.5.6 Others
  9.5.6 Historic and Forecasted Market Size By Application
   9.5.6.1 Cancer Diagnostics
   9.5.6.2 Cardiovascular Diagnostics
   9.5.6.3 Infectious Disease Diagnostics
   9.5.6.4 Neurological Diagnostics
   9.5.6.5 Pregnancy and Fertility Diagnostics
   9.5.6.6 Diabetes Diagnostics
   9.5.6.7 Others
  9.5.7 Historic and Forecasted Market Size By End-User
   9.5.7.1 Hospitals
   9.5.7.2 Diagnostic Laboratories
   9.5.7.3 Research Institutions
   9.5.7.4 Home Care
   9.5.7.5 Others
  9.5.8 Historic and Forecast Market Size by Country
   9.5.8.1 China
   9.5.8.2 India
   9.5.8.3 Japan
   9.5.8.4 South Korea
   9.5.8.5 Malaysia
   9.5.8.6 Thailand
   9.5.8.7 Vietnam
   9.5.8.8 The Philippines
   9.5.8.9 Australia
   9.5.8.10 New Zealand
   9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Vitro Diagnostics Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Product
   9.6.4.1 Instruments
   9.6.4.2 Reagents
   9.6.4.3 Software
   9.6.4.4 Others
  9.6.5 Historic and Forecasted Market Size By Technique
   9.6.5.1 Immunoassays
   9.6.5.2 Clinical Chemistry
   9.6.5.3 Molecular Diagnostics
   9.6.5.4 Hematology
   9.6.5.5 Microbiology
   9.6.5.6 Others
  9.6.6 Historic and Forecasted Market Size By Application
   9.6.6.1 Cancer Diagnostics
   9.6.6.2 Cardiovascular Diagnostics
   9.6.6.3 Infectious Disease Diagnostics
   9.6.6.4 Neurological Diagnostics
   9.6.6.5 Pregnancy and Fertility Diagnostics
   9.6.6.6 Diabetes Diagnostics
   9.6.6.7 Others
  9.6.7 Historic and Forecasted Market Size By End-User
   9.6.7.1 Hospitals
   9.6.7.2 Diagnostic Laboratories
   9.6.7.3 Research Institutions
   9.6.7.4 Home Care
   9.6.7.5 Others
  9.6.8 Historic and Forecast Market Size by Country
   9.6.8.1 Turkey
   9.6.8.2 Bahrain
   9.6.8.3 Kuwait
   9.6.8.4 Saudi Arabia
   9.6.8.5 Qatar
   9.6.8.6 UAE
   9.6.8.7 Israel
   9.6.8.8 South Africa
 9.7. South America Vitro Diagnostics Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Product
   9.7.4.1 Instruments
   9.7.4.2 Reagents
   9.7.4.3 Software
   9.7.4.4 Others
  9.7.5 Historic and Forecasted Market Size By Technique
   9.7.5.1 Immunoassays
   9.7.5.2 Clinical Chemistry
   9.7.5.3 Molecular Diagnostics
   9.7.5.4 Hematology
   9.7.5.5 Microbiology
   9.7.5.6 Others
  9.7.6 Historic and Forecasted Market Size By Application
   9.7.6.1 Cancer Diagnostics
   9.7.6.2 Cardiovascular Diagnostics
   9.7.6.3 Infectious Disease Diagnostics
   9.7.6.4 Neurological Diagnostics
   9.7.6.5 Pregnancy and Fertility Diagnostics
   9.7.6.6 Diabetes Diagnostics
   9.7.6.7 Others
  9.7.7 Historic and Forecasted Market Size By End-User
   9.7.7.1 Hospitals
   9.7.7.2 Diagnostic Laboratories
   9.7.7.3 Research Institutions
   9.7.7.4 Home Care
   9.7.7.5 Others
  9.7.8 Historic and Forecast Market Size by Country
   9.7.8.1 Brazil
   9.7.8.2 Argentina
   9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research